» Authors » Prasad Deshpande

Prasad Deshpande

Explore the profile of Prasad Deshpande including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 161
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulkarni V, Alexander M, Bhosale R, Jain D, Deshpande P, Gitlin E, et al.
J Clin Tuberc Other Mycobact Dis . 2025 Jan; 38:100504. PMID: 39758562
Background: Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+...
2.
Diebold P, Rhee M, Shi Q, Trung N, Umrani F, Ahmed S, et al.
Nat Commun . 2023 Nov; 14(1):7366. PMID: 37963868
The acquisition of antimicrobial resistance (AR) genes has rendered important pathogens nearly or fully unresponsive to antibiotics. It has been suggested that pathogens acquire AR traits from the gut microbiota,...
3.
Tuddenham S, Shafiq M, Mathad J, Alexander M, Naik S, Kulkarni V, et al.
J Acquir Immune Defic Syndr . 2023 May; 93(5):422-430. PMID: 37155962
Background: Bacterial vaginosis (BV) is a highly prevalent disorder of the cervicovaginal microbiota. Molecular-BV may put women at increased risk for adverse reproductive and obstetric outcomes. We investigated the association...
4.
Admase A, Joshi S, Borse R, Deshpande P, Kulkarni V, Khaire S, et al.
BMC Infect Dis . 2023 Apr; 23(1):233. PMID: 37069524
Background: People living with HIV (PLHIV) are at higher risk for human papillomavirus (HPV)-related oropharyngeal cancers compared to the general population. Xpert HPV test is a polymerase chain reaction (PCR)...
5.
Baidya A, Sangle S, Marbaniang I, Kulkarni V, Deshpande P, Nimkar S, et al.
Open Forum Infect Dis . 2022 Jul; 9(7):ofac233. PMID: 35836747
Background: Despite antiretroviral therapy, chronic lung diseases remain an important source of morbidity and mortality in people with HIV (PWH). We sought to identify clinical and immunological markers of pulmonary...
6.
Marbaniang I, Joshi S, Sangle S, Khaire S, Thakur R, Chavan A, et al.
PLoS One . 2022 Jul; 17(7):e0270876. PMID: 35788753
Introduction: In India, smokeless tobacco (SLT) is a predominant form of tobacco used among people living with HIV (PLHIV). Despite SLT being a risk factor for oral potentially malignant disorders...
7.
Chebrolu P, Sangle S, Nimkar S, Salvi S, Chavan A, Kulkarni V, et al.
Diabetes Metab Syndr . 2022 Jul; 16(7):102551. PMID: 35777254
Background: People living with HIV have greater diabetes (T2DM) than the general population despite lower prevalence of overweight/obesity. Both insulin resistance (IR), a T2DM precursor, and HIV are independently associated...
8.
Bhawsar S, Pawar S, Deshpande P, Yeole R, Chavan R, Nandanwar M, et al.
Bioorg Med Chem Lett . 2022 Jun; 71:128842. PMID: 35680102
Increased resistance to gram positive infections have highlighted the limitations of currently available drug treatments including penicillins, macrolides and glycopeptides. As an alternative to address these challenges; Linezolid, the first...
9.
Bhawsar S, Joshi S, Deshpande P, Yeole R, Bhagwat S, Patel M
Bioorg Med Chem Lett . 2022 Mar; 63:128665. PMID: 35276361
Novel antibacterial agents needed constantly to counter the ever emergent resistance development to commercially available drugs; one of the effective synthetic antibacterial classes is fluoroquinolone (FQ). This study includes structure...
10.
Shafiq M, Mathad J, Naik S, Alexander M, Yadana S, Araujo-Pereira M, et al.
JAMA Netw Open . 2021 Dec; 4(12):e2140584. PMID: 34935918
Importance: The association of elevated levels of specific inflammatory markers during pregnancy with adverse birth outcomes and infant growth could indicate pathways for potential interventions. Objective: To evaluate whether higher...